Silverman, L., Fenaux, P., Al-Kali, A., Baer, M., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D., Kambhampati, S., Kreuzer, K., Godley, L., Collins, R., Atallah, E., Navada, S., Azarnia, N., & Garcia-Manero, G. (n.d.). 88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?. Leukemia research, 39, S44–S45. http://access.bl.uk/ark:/81055/vdc_100059908817.0x000001